4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:动物毒液多肽毒素
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > acid_base_buffer_solution > Smartox/α1β1整合素与IV型胶原结合抑制剂/10OBT001-01000/1mg
商品详细Smartox/α1β1整合素与IV型胶原结合抑制剂/10OBT001-01000/1mg
Smartox/α1β1整合素与IV型胶原结合抑制剂/10OBT001-01000/1mg
Smartox/α1β1整合素与IV型胶原结合抑制剂/10OBT001-01000/1mg
商品编号: 10OBT001-01000
品牌: smartox-biotech
市场价: ¥14851.20
美元价: 11424.00
产地: 美国(厂家直采)
公司:
产品分类: 酸碱缓冲液
公司分类: acid_base_buffer_solution
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍

Obtustatin isa41aminoaciddisintegrinpeptideisolatedfromthevenomoftheViperalebetinaobtusa.Itisapotent(IC50 =2nM)and selectiveinhibitorofthebindingofα1β1 integrintocollagenIV.Contrarytootherknowndisintegrins,itdoesnotcontaintheclassicalRGDsequence. Obtustatin doesnotshowinhibitoryactivitytowardotherintegrins,includingα2β1IIbβ3vβ34β15β16β1,andα9β14β7 integrins. Obtustatin potentlyinhibitsangiogenesisinchickenandinmousemodelandreducestumordevelopmentbyhalf.


Description:

Productcode:10OBT001.Category:Integrins.Tag:integrin.

AAsequence: Cys1-Thr-Thr-Gly-Pro-Cys6-Cys7-Arg-Gln-Cys10-Lys-Leu-Lys-Pro-Ala-Gly-Thr-Thr-Cys19-Trp-Lys-Thr-Ser-Leu-Thr-Ser-His-Tyr-Cys29-Thr-Gly-Lys-Ser-Cys34-Asp-Cys36-Pro-Leu-Tyr-Pro-Gly-OH
Disulfidebonds: Cys1-Cys10,Cys6-Cys29,Cys7-Cys34 andCys19-Cys36
Length(aa): 41
Formula: C184H284N52O57S8
MolecularWeight: 4393.13 Da
Appearance:Whitelyophilizedsolid
Solubility: aqueousbuffer
CASnumber: notavailable
Source: Synthetic
Purityrate: >97%

Reference:

StructuralanddynamicalpropertiesofKTS-disintegrins:AcomparisonbetweenObtustatinandLebestatin

ObtustatinandLebestatinarelysine-threonine-serine(KTS)-disintegrins,whichareafamilyoflowmolecularweightpolypeptidespresentinmanyviperidaevenomsandarepotentandspecificinhibitorsofcollagen-bindingintegrins.Theintegrinbindingloop,harboringthe(21)KTS(23)motif,andtheC-terminaltailareknowntoberesponsIBLefortheselectivebindingtotheα1β1integrin.Despiteaveryhighsequencehomology(onlytwomutationsarepresentinLebestatinrelativetoObtustatin,namelyR24LandS38L),LebestatinexhibitsahigherinhibitoryeffectthanObtustatinoncelladhesionandcellmigrationtocollagensIandIV.Hereweshow,bymeansofmoleculardynamicssimulationsofthetwopolypeptidesinaqueoussolution,thatLebestatinpossessesahigherflexibilityoftheC-terminaltailandagreatersolventaccessibilityoftheintegrinbindingloopthanObtustatin.Itmaybehypothesizedthatthesepropertiesmaycontributetothehigherbinding-affinityofLebestatintoitsBIOLOGicalpartner.©2012WileyPeriodicals,Inc.

DaidoneI, etal. (2013)StructuralanddynamicalpropertiesofKTS-disintegrins:AcomparisonbetweenObtustatinandLebestatin. Biopolymers. PMID: 23097229

Angiostaticactivityofobtustatinasalpha1beta1integrininhibitorinexperimentalmelanomagrowth

Thepresentedresultsshowtheeffectoftargetingofcollagenreceptor,alpha1beta1integrinexpressedontheendothelialcellsonthedevelopmentofexperimentalmelanomaandpathologicalangiogenesis.Obtustatin,asnakevenomKTS-disintegrin,wasappliedasaspecificinhibitorofthisintegrin.Thislowmolecularweightpeptiderevealedapotenttherapeuticeffectonmelanomaprogressionin2animalsystems,mouseandquail.Itsoncostaticeffectwasrelatedtotheinhibitionofangiogenesis.ObtustatininhibitedtheneovascularizationratioontheCAMembryoofquail,whichwaspathologicallyinducedbythedevelopingtumor.Thei.v.admiNISTrationofobtustatincompletelyblockedcancergrowthofMV3humanmelanomainnudemice.InB16F10syngeneicmousemodeltreatmentwiththedisintegrinrevealedalowereffect,althoughthedevelopmentofthetumorwassignificantlyreducedforbothdosages.Themechanismofobtustatinactionisrelatedtotheblockingofmicrovascularendothelialcellproliferation,whichundergoesapoptosisincaspase-dependentmanner.Summarizing,wepresentstudiesoflowmolecularweightdisintegrin,obtustatinasapotentialtherapeuticcompoundfortreatmentofmelanomathatcontainahighlevelofvascularization.

BrownMC, etal. (2008)Angiostaticactivityofobtustatinasalpha1beta1integrininhibitorinexperimentalmelanomagrowth.IntJCancer. PMID: 18712720

KTSandRTS-disintegrins:anti-angiogenicvipervenompeptidesspecificallytargetingthealpha1beta1integrin

Integrinsalpha(1)beta(1)andalpha(2)beta(1)arehighlyexpressedonthemicrovascularendothelialcells,andblockingoftheiradhesivepropertiessignificantlyreducedtheVEGF-drivenneovascularizationratioandtumorgrowthinanimalmodels.Hence,inhibitorsofthealpha(1)beta(1)andalpha(2)beta(1)integrins,aloneorincombinationwithantagonistsofotherintegrinsinvolvedinangiogenesis(eg.alpha(v)beta(3),alpha(v)beta(5),andalpha(6)beta(4)),mayprovebeneficialinthecontroloftumorneovascularization.Viperidaesnakeshavedevelopedintheirvenomsanefficientarsenalofintegrinreceptorantagonists.KTS-(obtustatin,viperistatin,lebestatin)andRTS-(jerdostatin)disintegrinsrepresentvipervenompeptidesthatspecificallyblocktheinteractionofthealpha(1)beta(1)integrinwithcollagensIVandIinvitroandangiogenesisinvivo.Thepossibletherapeuticapproachtowardstumorneovascularizationbytargetingthealpha(5)beta(1),alpha(v)beta(5)andalpha(v)beta(3)integrinswithRGD-bearingdisintegrinshasbeenexploredinanumberoflaboratories.Herewediscussstructure-functioncorrelationsofthenovelgroupofspecific(K/R)TS-disintegrinstargetingthealpha(1)beta(1)integrin.

CalveteJJ, etal. (2007)KTSandRTS-disintegrins:anti-angiogenicvipervenompeptidesspecificallytargetingthealpha1beta1integrin. CurrPharmDes. PMID: 17979730

Aminoacidsequenceandhomologymodelingofobtustatin,anovelnon-RGD-containingshortdisintegrinisolatedfromthevenomofViperalebetinaobtusa

Disintegrinsrepresentagroupofcysteine-richpeptidesoccurringinCrotalidaeandViperidaesnakevenoms,andarepotentantagonistsofseveralintegrinreceptors.Anoveldisintegrin,obtustatin,wasisolatedfromthevenomoftheViperalebetinaobtusaviper,andrepresentsthefirstpotentandselectiveinhibitorofthebindingofintegrinalpha(1)beta(1)tocollagenIV.Theprimarystructureofobtustatincontains41aminoacidsandistheshortestdisintegrindescribedtodate.Obtustatinsharesthepatternofcysteinesofothershortdisintegrins.However,incontrasttoknownshortdisintegrins,theintegrin-bindingloopofobtustatinistworesiduesshorteranddoesnotexpresstheclassicalRGDsequence.Usingsyntheticpeptides,aKTSmotifwasidentifiedastheintegrin-bindingsequence.Athree-dimensionalmodelofobtustatin,builtbyhomology-modelingstructurecalculationsusingdifferenttemplatesandalignments,stronglyindicatesthatthenovelKTSmotifmayresideatthetipofaflexibleloop.

Moreno-MurcianoM.P., etal.(2003)Aminoacidsequenceandhomologymodelingofobtustatin,anovelnon-RGD-containingshortdisintegrinisolatedfromthevenomofViperalebetinaobtusa. ProteinSci. PMID: 12538900

Obtustatin:apotentselectiveinhibitorofalpha1beta1integrininvitroandangiogenesisinvivo

Anoveldisintegrin,obtustatin,waspurifiedfromthevenomoftheViperalebetinaobtusaviper.Obtustatinistheshortestdisintegrinyetdescribed,containingonly41aminoacids.ItcontainsasimilarpatternofcysteinestotheshortdisintegrinsechistatinanderistostatinbutcontainsthesequenceKTSratherthanRGDinitsactivesiteloop.Obtustatinisapotentandselectiveinhibitorofalpha1beta1integrin.Itdoesnotinhibitthecloselyrelatedintegrinalpha2beta1,norapanelofotherintegrinstested.Itdoesnotinhibitligandbindingtotherecombinantalpha1I-domain.Importantly,obtustatinpotentlyinhibitedangiogenesisinvivointhechickenchorioallantoicmembraneassay,andintheLewislungsyngeneicmousemodel,itreducedtumordevelopmentbyhalf,confirmingandextendingpreviousresultsontherelevanceofalpha1beta1integrintoangiogenesisandsuggestingnovelapproachestothegenerationofangiogenesisinhibitors.

MarcinkiewiczC., etal.(2003)Obtustatin:apotentselectiveinhibitorofalpha1beta1integrininvitroandangiogenesisinvivo. CancerRes. PMID: 12727812

NMRsolutionstructureofthenon-RGDdisintegrinobtustatin

Thesolutionstructureofobtustatin,anovelnon-RGDdisintegrinof41residuesisolatedfromViperalebetinaobtusavenom,andapotentandselectiveinhibitoroftheadhesionofintegrinalpha(1)beta(1)tocollagenIV,hasbeendeterminedbytwo-dimensionalnuclearmagneticresonance.Almostthewholesetofchemicalshiftsfor1H,13Cand15Nwereassignedatnaturalabundancefrom2Dhomonuclearandheteronuclear500MHz,600MHzand800MHzspectraatpH3.0recordedat298Kand303K.Finalstructuralconstraintsconsistedof302non-redundantNOE(95long-range,60medium,91sequentialand56intra-residue),fourdisulfidebonddistances,fivechi1dihedralanglesandfourhydrogenbonds.The20conformerswithlowesttotalenergyhadnoNOEviolationsgreaterthan0.35Aordihedralangleviolationsgreaterthan12degrees.Theaverageroot-mean-squaredeviation(RMSD)forbackboneatomsofallresiduesamongthe20conformerswas1.1Aand0.6Aforthe29best-definedresidues.Obtustatinlacksanysecondarystructure.ComparedtoallknowndisintegrinstructuresinwhichtheRGDmotifislocatedattheapexofan11residuehairpinloop,theactiveKTStripeptideofobtustatinisorientedtowardsasideofitsnineresidueintegrin-bindingloop.TheC-terminaltailisneartotheactiveloop,andthesetwostructuralelementsdisplaythelargestatomicdisplacementsduetolocalconformationaldisorder.Doublecross-peaksforW20,Y28andH27inthearomaticregionofTOCSYspectra,localRMSDvaluesfortheseresidues,andpositivecross-peaksinaROESYspectrum(600MHz,100msmixingtime),suggestthattheseresiduesactasahingeallowingfortheoverallflexibilityoftheentireintegrin-bindingloop.Thesedistinctstructuralfeatures,alongwithitsdifferentelectrostaticsurfacepotentialinrelationtootherknowndisintegrins,mayconfertoobtustatinitsreportedalpha(1)beta(1)integrininhibitoryselectivity.

Moreno-MurcianoM.P., etal.(2003)NMRsolutionstructureofthenon-RGDdisintegrinobtustatin. J.Mol.Biol. PMID: 12742023

品牌介绍
Smartox Biotechnology 是全球唯一一家专门生产动物毒液多肽毒素,用于细胞离子通道功能研究的生物医药公司。多肽毒素在生物制药领域具有重要的使用价值。Smartox Biotechnology 于 2009 年由来自 Grenoble 神经科学研究所 (Grenoble Institute of Neuroscience) 的 Michel de waard 博士创立, Smartox Biotechnology 专门研究动物毒液,制作合成多种毒液中的多肽成分(常称为毒素)。 De Waard 博士研究离子通道与毒素多肽的关系,尤其是鉴定、开发毒素多肽作为治疗性分子或细胞穿透肽 (cell penetrating peptides, CPP) 。其研究团队在毒液分离,药理性活性肽鉴定、富半胱氨酸肽定性、制作和优化等方面具有独特、丰富的经验。 2010 年, Smartox Biotechnolgy 被法国研究部 (Ministry of Research) 授予“新兴企业 OSEO 奖 (OSEO prize for emerging businesses) ”。